HORIBA Acquires Cameron's Process Analytical Division
News Apr 02, 2013
This development plays a key role in our longer term strategy and proactively addresses the rapidly evolving demands in the energy sector that are largely driven by shale gas and oil.
In response to growth in the petrochemical processing industry driven by the rapid expansion of shale gas production and a generally healthy energy economy, HORIBA has acquired the process analytical division of Cameron, a Houston, Texas based U.S. corporation. Cameron's primary business focuses on products, systems, and services addressing the needs of drilling, fluid transportation, oil and gas production, refining, and other petroleum processes. Their process analytical division focused on integrating measurement systems and providing service to support downstream petroleum production processes. Cameron's process analytical systems business mates well with HORIBA's existing expertise in environmental systems. Through this acquisition, HORIBA aims to enter the process analytical business, and takes a major step to expand our future core business. Synergies will be realized by incorporating the newly acquired process know-how into our existing technologies, adapting and interfacing our products to the unique sample handling requirements demanded by the refining and chemical markets, and leveraging our extensive sales and support network. As a result, we are targeting a six-fold growth in combined sales for our Process and Environmental segment by 2018.
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018